Fetal outcomes after rituximab exposure in women with autoimmune vasculitis

Ítems similars

• Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
  per: Cortazar, Frank B., et al.
  Publicat: (2017)
• The effect of continuous B cell depletion with rituximab on pathogenic autoantibodies and total IgG levels in ANCA vasculitis
  per: Cortazar, Frank B., et al.
  Publicat: (2017)
• Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
  per: Pendergraft, William F., et al.
  Publicat: (2014)
• Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  per: Rhee, Eugene P., et al.
  Publicat: (2010)
• Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease
  per: Zonozi, Reza, et al.
  Publicat: (2020)